compounded semaglutide new market Size, Share & Trends Report, 2025-2035 Despite FDA ruling, compounded GLP-1s
Description
Consider a short-term increase in therapy intensity: some patients benefit from psychological support (counseling or group programs) or meal-planning assistance during weaning
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), as well as the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound), may contribute to this uncomfortable symptom through their effects on digestion
Beyond geography, the burden of hypertension is not uniformly distributed by gender or residence
Switching compounds is clinically sound
